DOI QR코드

DOI QR Code

Use of Transgenic and Mutant Animal Models in the Study of Heterocyclic Amine-induced Mutagenesis and Carcinogenesis

  • Dashwood, Roderick H. (Department of Environmental & Molecular Toxicology, and Linus Pauling Institute, Oregon State University)
  • Published : 2003.01.31

Abstract

Heterocyclic amines (HCAs) are potent mutagens generated during the cooking of meat and fish, and several of these compounds produce tumors in conventional experimental animals. During the past 5 years or so, HCAs have been tested in a number of novel in vivo murine models, including the following: lacZ, lacI, cII, c-myc/lacZ, rpsL, and $gpt{\Delta}$ transgenics, $XPA^{-/-}$, $XPC^{-/-}$, $Msh2^{+/-}$, $Msh2^{-/-}$ and $p53^{+/-}$ knock-outs, Apc mutant mice ($Apc^{{\Delta}716}$, $Apc^{1638N}$, $Apc^{min}$), and $A33^{{\Delta}N{\beta}-cat}$ knock-in mice. Several of these models have provided insights into the mutation spectra induced in vivo by HCAs in target and non-target organs for tumorigenesis, as well as demonstrating enhanced susceptibility to HCA-induced tumors and preneoplastic lesions. This review describes several of the more recent reports in which novel animal models were used to examine HCA-induced mutagenesis and carcinogenesis in vivo, including a number of studies which assessed the inhibitory activities of chemopreventive agents such as 1,2-dithiole-3-thione, conjugated linoleic acids, tea, curcumin, chlorophyllin-chitosan, and sulindac.

Keywords

References

  1. Andreassen, A., Mollersen, L., Vikse, R., Steffensen, I. L., Mikalsen, A., Paulsen, J. E. and Alexander, J. (2002) One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo(4,5-f]quinoline (IQ) induces tumours in Minl/+ mice by truncation mutations or LOH in the Apc gene. Mutat. Res. 517,157-166. https://doi.org/10.1016/S1383-5718(02)00065-7
  2. Andreassen, A., Vikse, R., Steffensen. I. L., Paulsen. J. E. and Alexander, J. (2001) Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[ 4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type $Apc^{+}$ allele. Mutagenesis 16, 309-315. https://doi.org/10.1093/mutage/16.4.309
  3. Anzai, N., Taniyama, T., Nakandakari, N., Sugiyama, C., Negishi, T., Hayatsu, H and Negishi, K. (2001) Inhibition of DNA adduct fonnation and mutagenic action of 3-amino-1-methyl- 5H-pyrido[4,3-b]indole by chlorophyllin-chitosan in rpsL transgenic mice. Jpn. J. Cancer Res. 92, 848-853. https://doi.org/10.1111/j.1349-7006.2001.tb01171.x
  4. Bol. S. A. Horlbeck, J., Markovic, J., de Boer, J. G., Turesky, R. J. and Constable, A. (2000) Mutational analysis of the liver, colon and kidney of Big Blue rats treated with 2-amino-3- methylimidazo[4,5-f]quinoline. Carcinogenesis 21, 1-6. https://doi.org/10.1093/carcin/21.1.1
  5. Collett, G. P., Robson, C. N., Mathers, J. C. and Campbell, F. C. (2001) Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour fonnalion in Apc(min) mice. Carcinogenesis 22, 821-825. https://doi.org/10.1093/carcin/22.5.821
  6. Dashwood, R. H. (2002) Modulation of heterocyclic amine- induced mutagenicity and carcinogenicity: an 'A-to-Z' guide to chemopreventive agents, promoters, and transgenic models. Mutat. Res. 511, 89-112. https://doi.org/10.1016/S1383-5742(02)00005-4
  7. Dass, S. B., Bucci, T J., Heflich, R H. and Casciano, D. A (1999) Evaluation of the transgenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-tenn bioassay. Cancer Lett. 143, 81-85. https://doi.org/10.1016/S0304-3835(99)00196-2
  8. Davis, C. D., Dacquel, E. J., Schut, H. A J., Thorgeirsson, S. S and Snyderwine E G. (1996) In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta mice and c-mycl lacZ double transgenic mice. Mutat. Res. 356, 287-296. https://doi.org/10.1016/0027-5107(96)00074-7
  9. Felton, J. S., Knize, M. G., Salmon, C. P., Malfatti, M. A. and Kulp. K. S. (2002) Human exposure to heterocyclic amine food mutagens/carcinogens: relevance to breast cancer. Environ. Mol. Mutagen. 39, 112-118. https://doi.org/10.1002/em.10070
  10. Hein, D. W., Doll, M. A, Fretland, A J., Leff, M. A, Webb, S. J., Xiao. G. H., Devanaboyina, U. S., Nangju, N. A. and Feng, Y. (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers & PreV. 9, 29-42.
  11. Huelsken, J. and Behrens, J. (2002) The Wnt signalling pathway. J. Cell Sci. 115, 3977-3978. https://doi.org/10.1242/jcs.00089
  12. Itoh, T., Suzuki, T., Nishikawa, A., Furukawa, F., Takahashi, M., Xue, W., Sofuni, T. and Hayashi, M. (2000) In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4, 5-f]quinoxaline in lacl transgenic (Big Blue) mice. Mutat. Res. 468, 19-25. https://doi.org/10.1016/S1383-5718(00)00036-X
  13. Kakiuchi, H., Watanabe, M., Ushijima, T, Toyota, M., Imai, K., Weisburger, J. H., Sugimura, T. and Nagao, M. (1995) Specific 5'-GGGA-3'$\rightarrow$5'-GGA-3' mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine. Proc. Natl. Acad. Sci. USA 92, 910-904. https://doi.org/10.1073/pnas.92.3.910
  14. Klein, J. C., Beems, R B., Zwart, P. E., Hamzink, M., Zomer, G., van Steeg, H. and van Kreijl, C. F. (2001) Intestinal toxicity and carcinogenic potential of the food mutagen 2-amino-1- methyl-6-phenylimidazo[4,5-blpyridine (PhIP) in DNA repair deficient $XPA^{-/-}$ mice. Carcinogenesis 22, 619-626. https://doi.org/10.1093/carcin/22.4.619
  15. Lynch, A. M., Gooderham, N. J., Davies, D. S. and Boobis, A. R. (1998) Genetic analysis of PhIP intestinal mutations in MutaMouse. Mutagenesis 13, 601-605. https://doi.org/10.1093/mutage/13.6.601
  16. Masumura, K., Matsui, K., Yamada, M., Horiguchi, M., Ishida, K., Watanabe, M., Ueda, O., Suzuki, H., Kanke, Y., Tindall, K. R., Wakabayashi, K., Sofuni, T. and Nohmi, T. (1999) Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) in the new gpt delta transgenic mouse. Cancer Lett. 143, 241-244. https://doi.org/10.1016/S0304-3835(99)00132-9
  17. Masumura, K., Matsui, K., Yamada, M., Horiguchi, M., Ishida, K., Watanabe, M., Wakabayashi, K. and Nohmi, T. (2000) Characterization of mutations induced by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine in the colon of gpt delta transgenic mouse: novel G:C deletions beside runs of identical bases. Carcinogenesis 21, 2049-2056. https://doi.org/10.1093/carcin/21.11.2049
  18. Morimura, K., Salim, E. I., Yamamoto, S., Wanibuchi, H. and Fukushima, S. (1999) Dose-dependent induction of aberrant crypt foci in the colons but no neoplastic lesions in the livers of heterozygous p53-deficient mice treated with low dose 2- amino-3-methylimidazo[4,5-f]quinoline. Cancer Lett. 138, 81- 85. https://doi.org/10.1016/S0304-3835(98)00377-2
  19. Nagao, M. and Sugimura, T, eds. (2000) Food Borne Carcinogens: Heterocyclic Amines. Wiley & Sons, Chichester, England.
  20. Nagao. M., Ushijima, T., Watanabe, N., Okochi, E., Ochiai, M., Nakagama, H. and Sugimura, T. (2002) Studies on mammary carcinogenesis induced by a heterocyclic amine, 2-amino-1- methyl-6-phenylimidazo[4,5-b]pyridine, in mice and rats. Environ. Mol. Mutag. 39, 158-164. https://doi.org/10.1002/em.10047
  21. Okochi, E., Watanabe, N., Shimada, Y., Takahashi, S., Wakazono, K, Shirai, T., Sugimura. T., Nagao, M. and Ushijima, T. (1999) Preferential induction of guanine deletion at 5'-GGGA- 3' in rat mammary glands by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine. Carcinogenesis 20, 1933-1938. https://doi.org/10.1093/carcin/20.10.1933
  22. Orner, G. A., Dashwood, W.-M., Blum, C. A., Diaz, G. D., Li, Q., AI-Fageeh, M., Tebbutt, N., Heath, J. K, Ernst, M. and Dashwood, R. H. (2002a) Response of $Apc^{mim}$ and $A33^{\Delta\aleph\beta-cat}$ mutant mice to treatment with tea, sulindac, and 2-amino-1- methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Mutat. Res. 506, 121-127. https://doi.org/10.1016/S0027-5107(02)00158-6
  23. Orner, G. A, Dashwood, W.-M., Blum, C. A., Diaz, G. D., Li, Q. and Dashwood, R. H. (2002b) Suppression of tumorigenesis in the $Apc^{min}$ mouse: down-regulation of $\beta$-catenin signaling by a combination bf tea plus sulindac. Carcinogenesis, in press.
  24. Orner, G. A., Dashwood, W.-M., Li, Q., AI-Fageeh, M., Tebbutt, N., Heath, J. K, Ernst, M. and Dashwood, R. H. (2002c) Cellular effects of tea antioxidants in vitro and in mouse models of colorectal cancer: modulation of Wnt signaling. Free Radic. Res. 36, 16-20.
  25. Oshima, M., Oshima, H., Tsutsumi, M., Nishimura, S., Sugimura, T., Nagao, M. and Taketo, M. M. (1996) Effects of 2-amino-1- methyl-6-phenylimidazo[4,5-b]pyridine on intestinal polyp development in $Apc^{\Delta716}$ knockout mice. Mol. Carcinog. 15, 11- 17. https://doi.org/10.1002/(SICI)1098-2744(199601)15:1<11::AID-MC3>3.0.CO;2-V
  26. Park, C. B .. Kim, D. J., Uehara, N., Takasuka, N., Hiroyasu, B. T. and Tsuda, H. (1999) Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaiine (MeIQx) carcinogenicity. Cancer Lett. 139, 177-182. https://doi.org/10.1016/S0304-3835(99)00036-1
  27. Paulsen, J. E., Steffensen, I. L., Andreassen, A., Vikse, R. and Alexander, J. (1999) Neonatal exposure to the food mutagen 2- amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice. Carcinogenesis 20, 1277-1282. https://doi.org/10.1093/carcin/20.7.1277
  28. Polakis, P. (2000) Wnt signaling and cancer. Genes Dev. 14, 1837-1851.
  29. Ryu, D. Y., Pratt, V. S., Davis, C. D., Schut, H. A. and Snyderwine, E. G. (1999) In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in bitransgenic c-myc/lambda laeZ mice. Cancer Res. 59, 2587-2592.
  30. Schoeffner, D. J. and Thorgeirsson, U. P. (2000) Susceptibility of nonhuman primates to carcinogens of human relevance. in Vivo 14, 149-156.
  31. Schwab, C. E., Huber, W. W., Parzefall, W, Hietsch, G., Kassie, F., Schulte-Hermann, R and Knasmuller, S. (2000) Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Crit. Rev. Toxicol. 30, 1-69. https://doi.org/10.1080/10408440091159167
  32. Skog, K. (2002) Problems associated with the determination of heterocyclic amines in cooked foods and human exposure. Food Chem. Toxicol. 40, 1197-1203. https://doi.org/10.1016/S0278-6915(02)00052-2
  33. Skog, K. and Solyakov, A. (2002) Heterocyclic amines in poultry products: a literature review. Food Chem. Toxicol. 40, 1213-1221. https://doi.org/10.1016/S0278-6915(02)00062-5
  34. Sorensen, I. K., Kristiansen, E., Mortensen, A., van Kranen, H., van Kreijl, C., Fodde, R. and Thorgeirsson, S. S. (1997) Short- term carcinogenicity testing of a potent murine intestinal mutagen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), in $Apc^{1638N}$ transgenic mice. Carcinogenesis 18, 777- 781. https://doi.org/10.1093/carcin/18.4.777
  35. Steffensen, I. L., Paulsen, J. E. and Alexander, J. (2002) The food mutagen 2-amino-9H-pyrido[2,3-b]indole (AalphaC) but not its methylated form (MeAalphaC) increases intestinal tumorigenesis in neonatally exposed multiple intestinal neoplasia mice. Carcinogenesis 23, 1373-1378. https://doi.org/10.1093/carcin/23.8.1373
  36. Stuart, G. R, de Boer, J. G., Haesevoets, R., Holcroft, J., Kangas, J., Sojonky, K., Thorleifson, E., Thornton, A., Walsh, D. F., Yang, H. and Glickman, B. W. (2001) Mutations induced by 2- amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in cecum and proximal and distal colon of lacI transgenic rats. Mutagenesis 16,431-437. https://doi.org/10.1093/mutage/16.5.431
  37. Stuart, G. R., Thorleifson, E., Okochi, E., de Boer, J. G., Ushijima, T., Nagao, M. and Glickman, B. W. (2000) Interpretation of mutational spectra from different genes: analyses of PhIP-induced mutational specificity in the lacl and cll transgenes from colon of Big Blue rats. Mutat. Res. 452, 101-121. https://doi.org/10.1016/S0027-5107(00)00058-0
  38. Sugimura, T., Kawachi, T., Nagao, M., Yahagi, T., Seino, Y., Okamoto, T., Shudo, K., Kosuge, T., Tsuji, K., Wakabayashi, K., Iitaka, Y. and Itai, A. (1977) Mutagenic principle(s) in tryptophan and phenylalanine pyrolysis products. Proc. Jpn. Acad. 53, 58-61.
  39. Tebbutt, N. C., Johnstone, C. N., Demmler, K, Grail, D., Heath, J. K. and Ernst, M. (2000) Generation of mice expressing conditional oncogenes in intestinal epithelial cells. Proc. Am. Assoc. Cancer Res. 41, 848.
  40. Turesky, R. J. (2002) Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis. Drug Metab. Rev. 34, 625-650. https://doi.org/10.1081/DMR-120005665
  41. Widmark, E. M. P. (1939) Presence of cancer-producing substances in roasted food. Nature 143, 984.
  42. Yang, H., Stuart, G. R., Glickman, B. W. and de Boer, J. G. (2001) Modulation of 2-arnino-1-methyl-6-phenylimidazo[4,5- b]pyridine-induced mutation in the cecum and colon of big blue rats by conjugated linoleic acid and 1,2-dithiole-3-thione. Nutr. Cancer 39, 259-266. https://doi.org/10.1207/S15327914nc392_16
  43. Yang, H., Glickman, B. W. and de Boer, J. G. (2002) Sex-specific induction of mutations by PhIP in the kidney of male and female rats and its modulation by conjugated linoleic acid. Environ. Mol. Mutag. 40, 116-121. https://doi.org/10.1002/em.10096
  44. Zhang, S., Lloyd, R., Bowden, G., Glickman, B. W. and de Boer, J. G. (2001) Msh2 DNA mismatch repair gene deficiency and the food-borne mutagen 2-amino-1-methy-6-phenylimidazo[4,5- b]pyridine (PhIP) synergistically affect mutagenesis in mouse colon. Oncogene 20, 6066-6072. https://doi.org/10.1038/sj.onc.1204730

Cited by

  1. Mlh1-dependent suppression of specific mutations induced in vivo by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) vol.594, pp.1-2, 2006, https://doi.org/10.1016/j.mrfmmm.2005.08.011
  2. Metabolism and Biomarkers of Heterocyclic Aromatic Amines in Molecular Epidemiology Studies: Lessons Learned from Aromatic Amines vol.24, pp.8, 2011, https://doi.org/10.1021/tx200135s
  3. Intestinal Tumorigenesis in Min Mice is Enhanced by X-irradiation in an Age-dependent Manner vol.46, pp.1, 2005, https://doi.org/10.1269/jrr.46.83
  4. Polycyclic Aromatic Hydrocarbons and Digestive Tract Cancers: A Perspective vol.29, pp.4, 2011, https://doi.org/10.1080/10590501.2011.629974